Sophie's BioNutrients

  • DATABASE (335)

  • ARTICLES (484)

    • DATABASE (335)
    • ARTICLES (484)
  • Sort by
    • Relevance
    • Date

Pedro Diezma is an entrepreneur, author and professional speaker as well as a co-founder of AI software development company Acuilae. He previously founded Zerintia Technologies, which specializes in wearable technology, IoT and software and business processes and was its CEO until 2017. Diezma was also a senior project manager at Endesa and had developed projects for over 450 enterprises. As an author, his books include The Crown of Adam and The Rebirth of the Hero. According to Onalytica, Diezma is a top influencer on IoT and wearables. Diezma holds a degree in Business Administration and Management from Madrid's Complutense University. 

Entrepreneur First is a global entrepreneur incubator program and early-startup investor. The incubator is an intensive six-month program for founders and aspiring entrepreneurs to help them develop ideas that can go into building their own companies. The program is held in six cities around the world: Bangalore; Berlin, London, Paris, Singapore and Toronto (Canada).Participants do not need to have a startup or a specific business idea to participate, and those who have established their own companies can seek partners or co-founders at the program. Roughly 40-50% of the cohort reach the “Launch” phase, where the participants have established their own companies and received investments from Entrepreneur First and potentially other VCs. Entrepreneur First can invest in a startup built by program participants in exchange for 10% equity. The exact amount invested varies: £80,000 for the European programs; S$75,000 for the Singapore and Bangalore programs; and C$100,000 for the Canada program.

Geetest’s behavior-based authentication technology better protects websites from attacks and makes it easier for clients to verify web visitors.

New York-based VC firm Union Square Ventures (USV) was established in 2004 and has invested in more than 100 companies to date. It manages US$1.7bn in assets across nine funds. The most recent, totaling US$450m in commitments, was launched in 2019. USV invests across multiple sectors and all stages of investment. Its specific interest, however, is in businesses derived from academic theses. USV is a prolific investor: recent investments include blockchain-based gaming company Dapper Labs' US$11m Series A round and B2B loan marketplace C2FO's US$200m Series G round.

P101, which stands for Programma 101, the first PC ever made in history, is an Italian VC focused on early-stage investments founded and headed by Managing Partner Andrea Di Camillo. As of January 2021, the firm has between €70m and €100m available for investments. The fund is backed by The European Investment Fund, the Italian Investment Fund SGR, and Azimut, an Italian asset manager operating since 1989 and parent company of Azimut Holding, listed on the Milan Stock Exchange (AZM.IM).Headquartered in Milan, P101 has invested in international startups through its two funds, P101 and P102. It usually co-invests maintaining a lead investor role. According to Di Camillo, the P102 fund has a higher investment ticket, ranging between €2m–5m, with the possibility of increasing to up to €10m in a single company. The firm also manages Ita500, a €40m fund established in partnership with Azimut in January 2020. With a 10-year term, Ita500 will co-invest with P101’s first and second funds in startups with revenues of up to €5m and SMEs with a turnover range of €5m–50m.

Sorry, we couldn’t find any matches for“Sophie's BioNutrients”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.